This trial is no longer available!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Rheumatoid Arthritis
and you are
over 18
years old
The phase for this study is not defined.
Show me locations

The purpose

An expanded access trial of belimumab for named patients who participated in LBRA99.

Provided treatments

  • Drug: belimumab
Tris trial is registered with FDA with number: NCT00931086. The sponsor of the trial is Human Genome Sciences Inc., a GSK Company and it is looking for 0 volunteers for the current phase.
Official trial title:
An Expanded Access Trial of Belimumab Antibody (Monoclonal Anti-BLyS Antibody) in Patients With Rheumatoid Arthritis (RA) Who Were Previously Treated Under HGS Protocol LBRA99